| Dr Endre Dejuan Matthews, DC | |
|
108 E Northside Dr, Jackson, MS 39206-5417 | |
| (601) 366-9005 | |
| (601) 366-9005 |
| Full Name | Dr Endre Dejuan Matthews |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 24 Years |
| Location | 108 E Northside Dr, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457480469 | NPI | - | NPPES |
| 00125438 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1015 (Mississippi) | Primary |
| Provider Name | Matthews Chiropractic Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194955484 PECOS PAC ID: 0648323998 Enrollment ID: O20090804000155 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
How will pain care be influenced by the anticipated reforms in the U.S. healthcare system? Current models of healthcare delivery offer both obstacles and opportunities for achieving quality and effectiveness in pain-related care, according to Daniel Carr, MD, Tufts University in his keynote address at the American Pain Society Annual Scientific Meeting.
Pollution from coal mining may have a negative impact on public health in mining communities, according to data analyzed in a West Virginia University research study.
A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Endre Dejuan Matthews, DC 108 E Northside Dr, Jackson, MS 39206-5417 Ph: (601) 366-9005 | Dr Endre Dejuan Matthews, DC 108 E Northside Dr, Jackson, MS 39206-5417 Ph: (601) 366-9005 |
News Archive
Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it had received a Notice of Allowance from the United States Patent and Trademark Office for claims related to the use of mir-205 as a diagnostic in lung cancer.
How will pain care be influenced by the anticipated reforms in the U.S. healthcare system? Current models of healthcare delivery offer both obstacles and opportunities for achieving quality and effectiveness in pain-related care, according to Daniel Carr, MD, Tufts University in his keynote address at the American Pain Society Annual Scientific Meeting.
Pollution from coal mining may have a negative impact on public health in mining communities, according to data analyzed in a West Virginia University research study.
A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
› Verified 8 days ago
Dr. Jeremy Leumun, Marquis Coleman, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 5295 Galaxie Dr Ste C, Jackson, MS 39206 Phone: 601-214-3787 | |
Highway2health Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 2084 Dunbarton Dr, Ste C, Jackson, MS 39216 Phone: 662-836-8893 | |
Billie King, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 6351 I 55 N, Ste 121, Jackson, MS 39213 Phone: 601-373-1310 Fax: 601-373-6804 | |
Dr. Carl L Hunt, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1992 W Mcdowell Rd, Jackson, MS 39204 Phone: 601-371-1931 Fax: 601-371-1402 | |
Matthews Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 4515 Office Park Drive, Jackson, MS 39206 Phone: 601-366-9005 | |
Dr. Victoria Bass Shearer, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr Ste B, Jackson, MS 39216 Phone: 601-982-2916 Fax: 601-366-2916 | |
Dr. Edward Hunt, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 405 Briarwood Dr, Suite 207 F, Jackson, MS 39206 Phone: 601-991-3156 Fax: 601-991-3157 |